🇺🇸 FDA
Patent

US 10940188

Compounds and methods for treatment and prevention of Flavivirus infection

granted A61KA61K31/197A61K31/24

Quick answer

US patent 10940188 (Compounds and methods for treatment and prevention of Flavivirus infection) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Mar 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Mar 09 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K31/197, A61K31/24, A61K31/609, A61K38/00